This suggests that YKL-40 is a potential marker for in vitro cultured pro-inflammatory macrophages and is not a valuable biomarker in serum and sputum of patients with COPD treated with inhaled corticosteroids. The gene discussed is CHI3L1; the disease is chronic obstructive pulmonary disease.